Key result
Novel bovine jugular vein conduit maintains pliability with minimal thrombosis without anticoagulation in dogs.
Why the study?
An ideal extracardiac valved conduit for complex congenital cardiac anomaly repair has not been found due to complications like stenosis, thrombosis, calcification, and neointima peeling.
Does a diglycidyl ether-fixed, heparinized bovine jugular vein valved conduit maintain patency and pliability when implanted in a canine model?
Population
3 dogs in a preliminary animal study
Comparison
New biological valved conduit implantation without anticoagulants or antiplatelet drugs
Design
Preclinical study
Follow-up
3 to 5 months
Authors
Loading...
Supports further preclinical testing; leaves open translation to congenital cardiac repair pending larger studies.
Does a diglycidyl ether-fixed, heparinized bovine jugular vein valved conduit maintain patency and pliability when implanted in a canine model?
A novel diglycidyl ether-fixed bovine jugular vein valved conduit demonstrated promising pliability and antithrombogenicity in a preliminary canine model, suggesting potential for congenital cardiac anomaly repair.
Noishiki et al. (1993) studied Complex congenital cardiac anomalies (animal model) (n=3). Extracardiac valved conduit made of bovine jugular vein was evaluated on Graft patency, thrombosis, and pliability. A newly developed bovine jugular vein valved conduit implanted in 3 dogs maintained softness and pliability with only small thrombus areas at 3 to 5 months without anticoagulation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: